ADC Therapeutics SA (NYSE:ADCT) Stock Position Boosted by Deutsche Bank AG
Summary by defenseworld.net
1 Articles
1 Articles
All
Left
Center
1
Right
ADC Therapeutics SA (NYSE:ADCT) Stock Position Boosted by Deutsche Bank AG
Deutsche Bank AG increased its stake in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 40.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,062 shares of the company’s stock after acquiring an additional 16,217 shares during the period. Deutsche Bank AG owned approximately 0.06% of ADC Therapeutics worth $112,000 at the end of the most rece…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage